1,659 Shares in UnitedHealth Group Incorporated $UNH Acquired by ABN AMRO Bank N.V.

ABN AMRO Bank N.V. purchased a new position in UnitedHealth Group Incorporated (NYSE:UNH) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 1,659 shares of the healthcare conglomerate’s stock, valued at approximately $520,000.

A number of other institutional investors also recently bought and sold shares of the stock. Brighton Jones LLC raised its stake in UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock worth $22,384,000 after acquiring an additional 28,231 shares during the period. Revolve Wealth Partners LLC raised its position in shares of UnitedHealth Group by 137.1% during the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after purchasing an additional 2,324 shares during the period. SFE Investment Counsel boosted its holdings in UnitedHealth Group by 15.6% in the 1st quarter. SFE Investment Counsel now owns 549 shares of the healthcare conglomerate’s stock worth $288,000 after buying an additional 74 shares during the period. Gilbert & Cook Inc. raised its holdings in UnitedHealth Group by 2.6% during the first quarter. Gilbert & Cook Inc. now owns 1,605 shares of the healthcare conglomerate’s stock valued at $841,000 after acquiring an additional 41 shares during the period. Finally, Tempus Wealth Planning LLC lifted its stake in UnitedHealth Group by 9.0% in the 1st quarter. Tempus Wealth Planning LLC now owns 1,093 shares of the healthcare conglomerate’s stock worth $573,000 after purchasing an additional 90 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Trading Up 2.5%

Shares of NYSE UNH opened at $319.40 on Friday. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $622.83. The company has a quick ratio of 0.85, a current ratio of 0.82 and a debt-to-equity ratio of 0.71. The business has a fifty day simple moving average of $344.69 and a two-hundred day simple moving average of $316.94. The firm has a market cap of $289.32 billion, a PE ratio of 16.67, a price-to-earnings-growth ratio of 2.28 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, beating the consensus estimate of $2.87 by $0.05. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The firm had revenue of $113.16 billion for the quarter, compared to analyst estimates of $113.19 billion. During the same quarter last year, the firm posted $7.15 earnings per share. The business’s revenue for the quarter was up 12.2% on a year-over-year basis. Analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 16th. Investors of record on Monday, December 8th will be issued a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.8%. The ex-dividend date of this dividend is Monday, December 8th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 46.14%.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on the company. Deutsche Bank Aktiengesellschaft downgraded UnitedHealth Group from a “buy” rating to a “hold” rating and set a $333.00 target price on the stock. in a research report on Wednesday, October 29th. Sanford C. Bernstein increased their target price on UnitedHealth Group from $433.00 to $440.00 and gave the company an “outperform” rating in a research report on Thursday, October 30th. Oppenheimer reduced their price target on shares of UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating on the stock in a research report on Wednesday, July 30th. Jefferies Financial Group increased their price target on UnitedHealth Group from $317.00 to $409.00 and gave the company a “buy” rating in a report on Friday, October 17th. Finally, Mizuho increased their price target on UnitedHealth Group from $300.00 to $430.00 and gave the stock an “outperform” rating in a report on Thursday, October 9th. Eighteen investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat.com, UnitedHealth Group has an average rating of “Moderate Buy” and a consensus price target of $397.12.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.